Top Suppliers:I want be here


58652-20-3

58652-20-3 structure
58652-20-3 structure
  • Name: Nomegestrol acetate
  • Chemical Name: Nomegestrol acetate
  • CAS Number: 58652-20-3
  • Molecular Formula: C23H30O4
  • Molecular Weight: 370.482
  • Catalog: API Hormone and endocrine-regulating drugs Estrogen and progestogen drugs
  • Create Date: 2018-03-25 08:00:00
  • Modify Date: 2025-08-25 11:28:00
  • Nomegestrol acetate is a potent, highly selective progestogen, which is characterized as a full agonist at the progesterone receptor, with no or minimal binding to other steroid receptors, including the androgen and glucocorticoid receptors[1].

Name Nomegestrol acetate
Synonyms [(8S,9S,10R,13S,14S,17R)-17-acetyl-6,13-dimethyl-3-oxo-1,2,8,9,10,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate
EINECS 261-379-8
6-Methyl-3,20-dioxo-19-norpregna-4,6-dien-17-yl acetate
Lutenyl
(17a)-17-Acetyl-6-methyl-3-oxoestra-4,6-dien-17-yl acetate
MFCD00941390
17-Acetoxy-6-methyl-19-norpregna-4,6-diene-3,20-dione
Nomegestrol acetate
Estra-4,6-dien-3-one, 17-acetyl-17-(acetyloxy)-6-methyl-, (17α)-
19-normegestrol acetate
Description Nomegestrol acetate is a potent, highly selective progestogen, which is characterized as a full agonist at the progesterone receptor, with no or minimal binding to other steroid receptors, including the androgen and glucocorticoid receptors[1].
Related Catalog
Target

Progesterone receptor[1]

References

[1]. Mueck AO, et al. Nomegestrol acetate, a novel progestogen for oral contraception. Steroids. 2011 May;76(6):531-9.

Density 1.2±0.1 g/cm3
Boiling Point 507.3±50.0 °C at 760 mmHg
Molecular Formula C23H30O4
Molecular Weight 370.482
Flash Point 219.8±30.2 °C
Exact Mass 370.214417
PSA 60.44000
LogP 3.34
Vapour Pressure 0.0±1.3 mmHg at 25°C
Index of Refraction 1.554
Storage condition 2-8°C

CHEMICAL IDENTIFICATION

RTECS NUMBER :
RC8899200
CHEMICAL NAME :
19-Norpregna-4,6-diene-3,20-dione, 17-alpha-hydroxy-6-methyl-, acetate
CAS REGISTRY NUMBER :
58652-20-3
LAST UPDATED :
199603
DATA ITEMS CITED :
6
MOLECULAR FORMULA :
C23-H30-O4
MOLECULAR WEIGHT :
370.53

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
1050 ug/kg/21D-I
TOXIC EFFECTS :
Endocrine - changes in luteinizing hormone Endocrine - estrogenic Endocrine - effect on menstrual cycle
REFERENCE :
BJOGAS British Journal of Obstetrics and Gynaecology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.82- 1975- Volume(issue)/page/year: 94,1199,1987
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 9,657,1984
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 9,657,1984
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 9,657,1984
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 9,657,1984 ** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
5 mg/kg
SEX/DURATION :
female 4 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Fertility - other measures of fertility
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 33,710,1983
Symbol GHS08 GHS09
GHS08, GHS09
Signal Word Warning
Hazard Statements H361fd-H400
Precautionary Statements P280
Hazard Codes N
Risk Phrases 63-50
Safety Phrases 61
RIDADR UN 3077 9 / PGIII
RTECS RC8899200
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.